Search Results - "Amor, Imen Ben"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Life threatening hepatotoxicity induced by Nilotinib by Khelifa, Latifa, Ben Amor, Imen, Kassar, Olfa, Mdhaffer, Moez, Hdiji, Sondes, Elloumi, Moez

    Published in Journal of oncology pharmacy practice (01-03-2023)
    “…Introduction Tyrosine kinase inhibitor had changed the prognosis of chronic myeloid leukemia (CML) and the overall survival had reached 95%. Unfortunately,…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Non-Hodgkin's lymphoma developed during imatinib mesylate treatment of chronic myeloid leukemia by Kassar, Olfa, Kahla, Aicha Ben, Koubaa, Asma, Kallel, Faten, Amor, Imen Ben, Elloumi, Moez

    Published in Journal of oncology pharmacy practice (01-06-2023)
    “…Introduction Non-Hodgkin lymphoma induced by imatinib, as a tyrosine kinase inhibitor, is a rare complication. Case report A 54-year-old female with a history…”
    Get full text
    Journal Article
  14. 14

    Évaluation de la sexualité chez les sujets épileptiques by Hadj Ali, Amal, Ellouz, Emna, Ben Amor, Imen, Abbes, Wafa, Aloulou, Mariem

    Published in Revue neurologique (01-04-2024)
    “…L’épilepsie est l’une des affections neurologiques les plus fréquentes. Dans la littérature, l’incidence de la dysfonction sexuelle (DS) est élevée chez les…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Epidemiological and chronological profile of the parturientes in the extreme ages in the monastir region between 1994 and 2003 by Ben Salem, Kamel, El Mhamdi, Sana, Ben Amor, Imen, Sriha, Asma, Letaief, Mondher, Soussi Soltani, Mohamed

    Published in Tunisie Medicale (01-08-2010)
    “…Pregnancy outside 19 - 34 years interval is risk factors of the maternal and fetal morbidity and mortality. Tunisia, witch known an epidemiological transition,…”
    Get more information
    Journal Article